Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis.

[1]  N. Binkley,et al.  A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  B. Kiese,et al.  The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women. , 2012, Bone.

[3]  C. Christiansen,et al.  Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials , 2011, Journal of clinical pharmacology.

[4]  R. Heaney,et al.  Variability in the measured response of bone to teriparatide , 2011, Osteoporosis International.

[5]  W. Lems,et al.  PTH analogues and osteoporotic fractures , 2010, Expert opinion on biological therapy.

[6]  H. Iyer,et al.  Oral insulin – a review of current status , 2010, Diabetes, obesity & metabolism.

[7]  M. Castelli,et al.  Orally Administered Glucagon‐Like Peptide‐1 Affects Glucose Homeostasis Following an Oral Glucose Tolerance Test in Healthy Male Subjects , 2009, Clinical pharmacology and therapeutics.

[8]  N. Watts,et al.  Vertebral Fracture Risk Is Reduced in Women Who Lose Femoral Neck BMD With Teriparatide Treatment , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  L. Palermo,et al.  Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis , 2007, Osteoporosis International.

[10]  P. Delmas,et al.  Bone quality--the material and structural basis of bone strength and fragility. , 2006, The New England journal of medicine.

[11]  R. Isaacs,et al.  Stimulation of the growth of femoral trabecular bone in ovariectomized rats by the novel parathyroid hormone fragment, hPTH-(1–31)NH2 (Ostabolin) , 1996, Calcified Tissue International.

[12]  H. Dobnig.  A review of teriparatide and its clinical efficacy in the treatment of osteoporosis , 2004, Expert opinion on pharmacotherapy.

[13]  R. Lindsay,et al.  Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis , 2003 .

[14]  R. Marcus,et al.  The Skeletal Response to Teriparatide Is Largely Independent of Age, Initial Bone Mineral Density, and Prevalent Vertebral Fractures in Postmenopausal Women With Osteoporosis , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  P. Delmas,et al.  Treatment of postmenopausal osteoporosis , 2002, The Lancet.

[16]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[17]  R. Isaacs,et al.  Stimulation of Protein Kinase C Activity in Cells Expressing Human Parathyroid Hormone Receptors by C‐ and N‐Terminally Truncated Fragments of Parathyroid Hormone 1–34 , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  S. Mohan,et al.  Comparison of bone formation responses to parathyroid hormone(1-34), (1-31), and (2-34) in mice. , 2000, Bone.

[19]  G. Hendy,et al.  Comparison of the biochemical responses to human parathyroid hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans. , 1999, The Journal of clinical endocrinology and metabolism.

[20]  R. Isaacs,et al.  Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  R. Isaacs,et al.  Further definition of the protein kinase C activation domain of the parathyroid hormone , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.